StockNews.com Initiates Coverage on Streamline Health Solutions (NASDAQ:STRM)

StockNews.com assumed coverage on shares of Streamline Health Solutions (NASDAQ:STRM) in a report issued on Sunday. The brokerage set a “sell” rating on the stock.

Separately, Craig Hallum raised Streamline Health Solutions to a “strong-buy” rating in a report on Thursday, September 5th.

Streamline Health Solutions Price Performance

Shares of NASDAQ STRM opened at $0.19 on Friday. Streamline Health Solutions has a 1-year low of $0.19 and a 1-year high of $1.00. The business has a 50-day moving average of $0.49 and a 200-day moving average of $0.45. The company has a debt-to-equity ratio of 0.62, a current ratio of 0.76 and a quick ratio of 0.76. The company has a market capitalization of $12.03 million, a price-to-earnings ratio of -0.61 and a beta of 1.62.

Streamline Health Solutions (NASDAQ:STRM) last issued its quarterly earnings results on Wednesday, September 11th. The company reported ($0.05) EPS for the quarter, missing analysts’ consensus estimates of ($0.04) by ($0.01). The business had revenue of $4.48 million during the quarter. Streamline Health Solutions had a negative net margin of 92.72% and a negative return on equity of 43.21%.

Institutional Inflows and Outflows

A hedge fund recently bought a new stake in Streamline Health Solutions stock. Mesirow Financial Investment Management Inc. bought a new position in shares of Streamline Health Solutions, Inc. (NASDAQ:STRM) during the first quarter, according to the company in its most recent disclosure with the SEC. The firm bought 123,900 shares of the company’s stock, valued at approximately $59,000. Mesirow Financial Investment Management Inc. owned about 0.21% of Streamline Health Solutions as of its most recent SEC filing. 31.74% of the stock is owned by institutional investors and hedge funds.

About Streamline Health Solutions

Streamline Health Solutions, Inc offers health information technology solutions and associated services for hospitals and health systems in the United States and Canada. The company offers RevID, an automated revenue reconciliation software; eValuator, a coding analysis platform; data comparison engine; coding and clinical documentation improvement (CDI) solutions, including CDI, abstracting, and physician query; and financial management solutions, such as accounts receivable management, denials management, claims processing, spend management, and audit management.